Extracorporeal Membrane Oxygenation Machine Market Size & Growth Forecast 2027–2036, By Segments (Modality, Patient Type, Application, Component), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 357.7 million in 2026 and is projected to grow at a 5.13% CAGR from 2027 to 2036, crossing USD 589.91 million by 2036. The industry revenue for 2027 is calculated at USD 373.15 million.
Get more details on this report
Request Free Sample ReportExtracorporeal Membrane Oxygenation Machine Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 41.87% share in 2026, supported by advanced critical care infrastructure, specialized hospitals, and established ECMO adoption.
- Asia Pacific is projected to grow at a 6.33% CAGR as hospitals invest in critical care capacity and advanced life-support technologies.
Segment Momentum
- Adults represented 62.35% of the market in 2026 due to the higher volume of critical care cases requiring advanced cardiac and pulmonary life-support interventions in hospital settings.
- Veno-Arterial ECMO is expanding fastest because it supports both cardiac and respiratory function, making it highly valuable for managing severe cardiopulmonary failure and high-acuity patients.
Market Expansion Drivers
- Rising prevalence of cardiopulmonary diseases increasing demand for advanced ECMO life-support systems.
- Technological advancements in portable ECMO systems improving critical patient transport and surgical applications.
- Expanding geriatric population increasing long-term demand for advanced respiratory and cardiac support technologies.
Leading Market Participants
- Prominent players in the extracorporeal membrane oxygenation machine market include Medtronic plc (Ireland), Getinge AB (Sweden), Terumo Corporation (Japan), LivaNova PLC (United Kingdom), Nipro Corporation (Japan), MicroPort Scientific Corporation (China), CytoSorbents Corporation (United States), EUROSETS S.r.l. (Italy), Xenios AG (Germany), Medos Medizintechnik AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 357.7 million
- 2027 Estimated Market Size: USD 373.15 million.
- Projected Market Size: USD 589.91 million by 2036
- Growth Forecast: 5.13% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veno-Arterial (Modality) | Adult (Patient Type) | Respiratory (Application) | Oxygenator (Component)
- Emerging Opportunity Segment: Veno-Arterial (Modality) | Adult (Patient Type) | Respiratory (Application) | Oxygenator (Component)
Market Growth Drivers and Industry Trends
Rising prevalence of cardiopulmonary diseases increasing demand for advanced ECMO life-support systems
The increasing burden of severe cardiac and respiratory conditions is creating greater demand for advanced interventions that can temporarily support vital organ functions in critically ill patients. Rising cardiopulmonary diseases will drive the extracorporeal membrane oxygenation machine market as healthcare facilities require ECMO systems for patients experiencing severe respiratory or cardiac failure that cannot be adequately managed through conventional treatment alone. Greater clinical need for advanced life-support technologies is also encouraging hospitals to strengthen critical-care capabilities and access to specialized extracorporeal support.
Technological advancements in portable ECMO systems improving critical patient transport and surgical applications
Advances in ECMO technology are improving the portability and usability of systems used in highly specialized critical-care settings. Portable ECMO development will boost extracorporeal membrane oxygenation machine market demand by enabling greater flexibility in transporting critically ill patients while maintaining extracorporeal support during transfers. Improved portability also expands the practical application of ECMO during selected surgical and procedural settings, where compact and maneuverable systems can support patient management in environments requiring specialized cardiopulmonary assistance.
Expanding geriatric population increasing long-term demand for advanced respiratory and cardiac support technologies
Population aging is increasing the number of patients requiring complex medical care for conditions affecting respiratory and cardiovascular function, placing greater emphasis on advanced critical-care technologies. An expanding geriatric population will propel the extracorporeal membrane oxygenation machine market as healthcare providers encounter more complex cases requiring intensive respiratory or cardiac support. The broader need for specialized life-support capabilities can encourage hospitals to maintain advanced critical-care infrastructure and equipment for managing severe cardiopulmonary complications among older patients.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cardiopulmonary diseases increasing demand for advanced ECMO life-support systems | 1.80% | High | North America, Europe | High | Near Term |
| Technological advancements in portable ECMO systems improving critical patient transport and surgical applications | 1.50% | High | North America, Asia Pacific | Medium | Mid Term |
| Expanding geriatric population increasing long-term demand for advanced respiratory and cardiac support technologies | 1.30% | Moderate | North America, Asia Pacific | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the extracorporeal membrane oxygenation machine market, accounting for a 41.87% share in 2026, underpinned by advanced critical-care infrastructure, broad availability of specialized cardiovascular and intensive-care services, and established expertise in complex life-support procedures. The region's healthcare systems have strong capabilities for managing severe respiratory and cardiac failure, supporting the integration of extracorporeal life-support technologies into specialized clinical settings. Continued improvements in critical-care medicine, increasing clinical awareness of advanced life-support options, and investments in hospital infrastructure are contributing to market strength. The presence of multidisciplinary clinical teams and established training capabilities also facilitates the adoption and effective utilization of ECMO systems in high-acuity care environments.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth in the extracorporeal membrane oxygenation machine market, encouraged by improving critical-care infrastructure, expanding access to advanced medical technologies, and rising healthcare investment. Hospitals across developing healthcare systems are increasingly strengthening intensive-care and cardiovascular treatment capabilities, creating greater opportunities for advanced extracorporeal support technologies. Growing awareness among clinicians, improvements in specialist training, and the expansion of tertiary-care facilities are also helping broaden the availability of ECMO-based treatment. In addition, increasing healthcare expenditure and efforts to enhance emergency and critical-care capacity are supporting wider adoption, while continued modernization of hospitals is creating a favorable environment for the regional market's expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Hospital Technology IntegrationGermany prioritizes ECMO adoption through well-equipped university hospitals and structured critical care networks. The country focuses on equipment reliability, clinician expertise, and standardized treatment protocols that support consistent utilization across complex patient populations.
France 🇫🇷
Specialized Care NetworksFrance supports ECMO utilization through coordinated referral hospitals and specialized critical care centers. The country emphasizes clinical collaboration, standardized treatment pathways, and modernization of life-support equipment to strengthen intensive care delivery.
Italy 🇮🇹
Critical Care ModernizationItaly focuses on upgrading intensive care capabilities with ECMO systems that enhance treatment of complex respiratory and cardiac cases. Investment in hospital modernization and specialist training supports broader adoption across major healthcare institutions.
Japan 🇯🇵
Precision Critical CareJapan strengthens the ECMO market by emphasizing compact, high-performance systems suited for advanced hospital environments. Clinical preference for dependable life-support technologies and continuous refinement of intensive care capabilities supports sustained equipment demand.
South Korea 🇰🇷
Advanced Intensive CareSouth Korea continues expanding ECMO capabilities through investments in tertiary hospitals and emergency care infrastructure. The country encourages adoption of technologically advanced systems alongside specialized clinician training to improve management of severe cardiopulmonary conditions.
United States 🇺🇸
Critical Care InnovationThe U.S. emphasizes advanced ECMO deployment across tertiary hospitals, supported by expanding cardiac and respiratory critical care programs. Demand is reinforced by clinical training, technology upgrades, and integration of ECMO systems into specialized intensive care pathways.
Segment Leadership and Growth Trends
Extracorporeal Membrane Oxygenation Machine Market Share (%), by Modality, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportModality Segment Analysis: Veno-Arterial (Largest & Fastest-Growing Segment)
The veno-arterial segment led the extracorporeal membrane oxygenation machine market with a 44.73% share in 2026 and also represented the fastest-growing modality. Veno-arterial extracorporeal membrane oxygenation provides both cardiac and respiratory support, making it particularly important in critical care situations involving severe cardiovascular compromise alongside impaired oxygenation. Its broad clinical utility supports use in complex emergency and intensive-care scenarios where conventional support may be insufficient. Increasing awareness of advanced extracorporeal life-support approaches and the expansion of specialized critical-care capabilities are strengthening utilization. Improvements in ECMO equipment, circuit management, monitoring technologies, and clinical expertise are also supporting wider integration of veno-arterial support within advanced hospital care pathways.
Patient Type Segment Analysis: Adult (Largest & Fastest-Growing Segment)
Adult patients represented the largest and fastest-growing patient category in the extracorporeal membrane oxygenation machine market, accounting for a 62.35% share in 2026. The segment's leading position reflects the substantial use of extracorporeal support in adults experiencing severe cardiac or respiratory failure and other life-threatening conditions requiring advanced intensive-care intervention. Growing availability of specialized critical-care infrastructure and increasing clinical experience with ECMO are supporting its adoption among adult patients. Improvements in patient selection, circuit technology, monitoring, and multidisciplinary management are also helping healthcare providers use ECMO in increasingly complex cases. As hospitals continue strengthening advanced life-support capabilities, the adult patient segment remains a central contributor to ECMO utilization.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | Veno-Arterial, Veno-Venous, Arterio-Venous | Veno-Arterial | Veno-Arterial |
| Patient Type | Neonates, Pediatric, Adult | Adult | Adult |
| Application | Respiratory, Cardiac, ECPR | Respiratory | Respiratory |
| Component | Pumps, Oxygenator, Controllers, Cannula, Accessories | Oxygenator | Oxygenator |
Competitive Landscape and Market Positioning
Leading companies in the extracorporeal membrane oxygenation machine market:
1. Medtronic plc (Ireland)
2. Getinge AB (Sweden)
3. Terumo Corporation (Japan)
4. LivaNova PLC (United Kingdom)
5. Nipro Corporation (Japan)
6. MicroPort Scientific Corporation (China)
7. CytoSorbents Corporation (United States)
8. EUROSETS S.r.l. (Italy)
9. Xenios AG (Germany)
10. Medos Medizintechnik AG (Germany)
The extracorporeal membrane oxygenation machine market is progressing through advancements in life-support technologies and improved patient management systems for critical care applications. Healthcare providers are adopting next-generation ECMO devices with enhanced monitoring capabilities, portability, and operational efficiency. Growing emphasis on emergency respiratory support and intensive care modernization is also driving continued innovation within the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Getinge AB (Sweden) | |||||||
| Terumo Corporation (Japan) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Nipro Corporation (Japan) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| CytoSorbents Corporation (United States) | |||||||
| EUROSETS S.r.l. (Italy) | |||||||
| Xenios AG (Germany) | |||||||
| Medos Medizintechnik AG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Medtronic | Oct-25 | Medtronic launched VitalFlow, an all-in-one ECMO system specifically engineered for intuitive bedside operation in the European market. This system streamlines critical care workflows by integrating essential monitoring and support functions, representing a strategic focus on enhancing clinical usability and operational efficiency in high-acuity life support environments. |
| Abbott | Apr-23 | Abbott secured FDA clearance for the extended use of its CentriMag Blood Pump in adult patients requiring ECMO therapy. This regulatory milestone expands the indicated clinical application of the life support system, strengthening Abbott's competitive position by enabling long-term support for patients suffering from acute heart and lung failure. |
| LivaNova PLC | Nov-22 | LivaNova PLC received 510(k) FDA clearance for its next-generation LifeSPARC advanced circulatory support system. The regulatory approval enables the commercial deployment of the technology within the U.S. market, providing healthcare providers with a modernized platform for managing patients in need of extracorporeal life support. |
| Inspira Technologies OXY B.H.N Ltd. | Jul-22 | Inspira Technologies introduced the "Liby" System, an advanced life support platform designed to treat patients with acute heart and lung failure. This product launch expands the available options for non-invasive and minimally invasive life support, reflecting a strategic initiative to provide clinicians with specialized tools for managing patients in critical failure states. |
| LivaNova PLC | May-22 | LivaNova PLC acquired ALung Technologies, a biotechnology firm specializing in extracorporeal CO2 removal. This strategic acquisition directly bolsters LivaNova’s portfolio in the advanced circulatory and respiratory support market, providing the company with proprietary technology to enhance its integrated life support systems and scale its presence in the critical care segment. |
| MicroPort Scientific Corporation | Oct-21 | MicroPort Scientific Corporation acquired Hemovent GmbH, a German developer of extracorporeal life support systems. The acquisition included a commitment to expand Hemovent’s German operations, marking a significant strategic move by MicroPort to build its European R&D and manufacturing footprint while gaining access to advanced ECLS technology. |
| EUROSETS | Jan-21 | EUROSETS announced the commercial launch of ECMOLife, an extracorporeal life support system featuring advanced magnetic levitation centrifugal pump technology. The rollout of this platform outside the U.S. demonstrates the company’s focus on leveraging maglev innovations to improve blood handling and operational performance in life support systems for respiratory and cardiac therapy. |
| ABIOMED | Apr-20 | ABIOMED acquired Breethe, a medical device company that developed a portable ECMO system designed for managing cardiogenic shock and respiratory failure. This acquisition added compact, portable life support capabilities to ABIOMED's cardiovascular portfolio, enabling the company to address the growing demand for mobile and scalable extracorporeal therapy solutions in acute care settings. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Extracorporeal Membrane Oxygenation Machine Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Setting | Intensive Care Units, Operating Rooms, Emergency/Critical Care, Cardiac Catheterization Laboratories |
| Therapy Duration | Short-Term ECMO, Intermediate-Term ECMO, Prolonged ECMO |
| Purchase Model | Direct Capital Purchase, Leasing, Rental/Managed Equipment Services |
Extracorporeal Membrane Oxygenation Machine Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| ECMO Center of Excellence Benchmarking |
|
| Hospital ECMO Program Expansion Strategy |
|
| Patient Access and Treatment Gap Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the extracorporeal membrane oxygenation machine market generate?
How much is the extracorporeal membrane oxygenation machine industry expected to grow by 2036?
How are changing critical care requirements influencing ECMO procurement strategies?
Why are portable ECMO technologies becoming increasingly important in the market?
Why is the adult segment dominant in the extracorporeal membrane oxygenation machine market?
What makes Veno-Arterial ECMO the fastest-growing modality segment?
What factors make North America the leading ECMO machine market?
How is Asia Pacific expanding opportunities in the ECMO machine market?
What are the prominent companies operating in the extracorporeal membrane oxygenation machine landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization